Group A Streptococcal Tonsillopharyngitis: Cost-Effective Diagnosis and Treatment

Annals of Emergency Medicine

Volumn 25, Issue 3, 1995, Pages 390-403

  Pichichero, Michael E ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AZITHROMYCIN; CARBACEPHEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; CLARITHROMYCIN; CLINDAMYCIN; ERYTHROMYCIN; PENICILLIN G; PENICILLIN V; RIFAMPICIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ANTIGEN DETECTION; ANTIGEN SPECIFICITY; BACTERIUM ISOLATION; COST EFFECTIVENESS ANALYSIS; HUMAN; PATIENT COMPLIANCE; PHARYNGITIS; PRIORITY JOURNAL; PSEUDOMEMBRANOUS COLITIS; REVIEW; STREPTOCOCCUS GROUP A; TONSILLITIS;

ADOLESCENT; ADULT; CEPHALOSPORINS; CHILD; CHILD, PRESCHOOL; COST-BENEFIT ANALYSIS; DRUG ADMINISTRATION SCHEDULE; ERYTHROMYCIN; HUMAN; PENICILLIN RESISTANCE; PENICILLINS; PHARYNGITIS; PHARYNX; RECURRENCE; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; TONSILLITIS; TREATMENT FAILURE;

EID: 0028920202     PISSN: 01960644     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-0644(95)70300-4     Document Type: Article

References (147)

1. Current problems in managing streptococcal pharyngitis
2. Management of streptococcal pharyngitis reconsidered
3. Streptococcal pharyngitis in the 1980s
4. Streptococcal pharyngitis: Clearing up the controversies
5. Treatment of streptococcal pharyngotonsillitis: Reports of penicillin's demise are premature
6. Erythromycin therapy for group A streptococcal pharyngitis: Results of a comparative study of the estolate and ethylsuccinate formulations
7. Erythromycin in the treatment of streptococcal infections
8. Comparative efficacy and toxicity of roxithromycin and erythromycin ethylsuccinate in the treatment of streptococcal pharyngitis in adults
9. Comparison of the clinical and bacteriological efficacy of clarithromycin and erythromycin in the treatment of streptococcal pharyngitis
10. Group A beta-hemolytic streptococcal pharyngitis: Immediate treatment with penicillin, rapid diagnosis, and antibiotic selection
11. The compromises of managing acute pharyngitis
12. Controversies in the treatment of streptococcal pharyngitis
13. A comparison of cephalosporins and penicillins in the treatment of group A beta-hemolytic streptococcal pharyngitis: A meta-analysis supporting the concept of microbial co-pathogenicity
14. The rising incidence of penicillin treatment failures in group A streptococcal tonsillopharyngitis: An emerging role for the cephalosporins?
15. Alternatives to penicillin in the management of group A streptococcal pharyngitis
16. Explanations and therapies for penicillin failure in streptococcal pharyngitis
17. Treatment issues for group A b-hemolytic streptococcal pharyngitis and tonsillitis
18. Comparison of once-daily cefadroxil and four-times-daily erythromycin in group A streptococcal tonsillopharyngitis
19. Streptococcal pharyngitis and scarlet fever
20. Viral and bacterial organisms associated with acute pharyngitis in a school-aged population
21. Febrile exudative tonsillitis: Viral or streptococcal?
22. Pharyngitis in adults: The presence and coexistence of viruses and bacterial organisms
23. Pharyngitis associated with herpes simplex virus in college students
24. Clinical spectrum of pharyngeal gonococcal infection
25. Tonsillitis and rash associated with Corynebacterium haemolyticum
26. Corynebacterium haemolyticum as a cause of pharyngitis and scarlatiniform rash in young adults
27. Arcanobacterium haemolyticum: Biology of the organism and diseases in man
28. Arcanobacterium haemolyticum in children with presumed streptococcal pharyngotonsillitis or scarlet fever
29. Role of Chlamydia trachomatis in acute pharyngitis in young adults
30. Chlamydia pneumoniae strain TWAR, Mycoplasma pneumoniae, and viral infections in acute respiratory disease in a university student health clinic population
31. A simple scorecard for the tentative diagnosis of streptococcal pharyngitis
32. Recognition of streptococcal pharyngitis in adults
33. Association of Group C b-hemolytic streptococci with endemic pharyngitis among college students
34. b-Hemolytic non-group A streptococci and pharyngitis
35. Community-wide outbreak of group G streptococcal pharyngitis
36. Do the b-hemolytic non-group A streptococci cause pharyngitis?
37. Non-group A streptococci in the pharynx: Pathogens or innocent bystanders?
38. Nonstreptococcal pharyngitis
39. Rapid diagnosis of adenoviral tonsillitis: A prospective clinical study
40. Streptococcal pharyngitis: Clinical and epidemiologic factors
41. The accuracy of diagnosis of beta streptococcal infections on clinical grounds
42. Streptococcal pharyngitis Evaluation of clinical syndromes in diagnosis
43. Guidelines for the selective use of throat cultures in the diagnosis of streptococcal respiratory infection
44. Applicability of a scoring system in the diagnosis of streptococcal pharyngitis
45. The accuracy of experienced physicians' probability estimates for patients with sore throats: Implications for decision making
46. Culture and antigen detection tests for streptococcal tonsillopharyngitis
47. Comparative reliability of clinical, culture, and antigen detection methods for the diagnosis of group A beta-hemolytic streptococcal tonsillopharyngitis
48. The rapid identification of group A beta-hemolytic streptococci in the upper respiratory tract
49. Comparison of throat cultures and rapid strep tests for diagnosis of streptococcal pharyngitis
50. Clinical performance and effect on treatment rates of latex agglutination testing for streptococcal pharyngitis in an emergency department
51. Impact of rapid antigen tests for group A streptococcal pharyngitis on physician use of antibiotics and throat cultures
52. Clinical evaluation of a latex agglutination test for streptococcal pharyngitis: Performance and impact on treatment rates
53. Rapid group A streptococcal antigen detection kit: Effect on antimicrobial therapy for acute pharyngitis
54. Throat cultures and rapid tests for diagnosis of group A streptococcal pharyngitis
55. Suitability of throat culture procedures for detection of group A streptococci and as reference standards for evaluation of streptococcal antigen detection kits
56. Comparison of a latex agglutination test and four culture methods for identification of group A streptococci in a pediatric office laboratory
57. The diagnosis of group A, ß-hemolytic streptococcal pharyngitis in the office setting
58. Insensitivity of rapid antigen detection methods and single blood agar plate culture for diagnosing streptococcal pharyngitis
59. Novel, rapid optical immunoassay technique for detection of group A streptococci from pharyngeal specimens: Comparison with standard culture methods
60. Evaluation of the throat culture as a follow-up for an initially negative enzyme immunosorbent assay rapid streptococcal antigen detection test
61. Adult and pediatric pharyngitis: A review
62. An analysis of the cost-effectiveness of pharyngitis management and acute rheumatic fever prevention
63. Comparative costs of diagnosis and treatment in acute pharyngitis
64. The comparative cost-effectiveness of statistical decision rules and experienced physicians in pharyngitis management
65. Cost-effectiveness of rapid latex agglutination testing and throat culture for streptococcal pharyngitis
66. Prevention of rheumatic fever Treatment of the preceding streptococcic infection
67. Prophylaxis of acute rheumatic fever by treatment of the preceding streptococcal infection with various amounts of depot penicillin
68. The effect of penicillin prophylaxis on streptococcal disease rates and the carrier state
69. Treatment of beta hemolytic streptococcic infections in the home: Relative value of available methods
70. Observations in Air Force recruits, or streptococcal diseases and their control with orally administered penicillin
71. Penicillin V for group V streptococcal pharyngitis: A randomized trial of seven vs ten days' therapy
72. Five vs ten days of penicillin v therapy for streptococcal pharyngitis
73. Erythromycin-resistant group A beta-hemolytic streptococci: Prevalence at four medical centers
74. Penicillin tolerance and erythromycin resistance of group A b-hemolytic streptococci in Hawaii and the Philippines
75. Sensitivity of group A streptococci to antibiotics: Prevalence of resistance to erythromycin in Japan
76. Resistance to erythromycin in group A streptococci
77. A controlled trial of erythromycin in adults with nonstreptococcal pharyngitis
78. Comparison of oral cephalosporins with penicillin therapy for group A streptococcal pharyngitis
79. Efficacy of cefuroxime axetil suspension compared with penicillin V suspension in children with group A streptococcal pharyngitis
80. Comparative study of the effectiveness of cefixime and penicillin V for the treatment of streptococcal pharyngitis in children and adolescents
81. Cefprozil versus penicillin V in the treatment of streptococcal tonsillopharyngitis
82. Loracarbef versus penicillin VK in the treatment of streptococcal pharyngitis and tonsillitis
83. Ceftibuten versus penicillin V in group A beta-hemolytic streptococcal pharyngitis
84. Cefpodoxime proxetil vs penicillin V in pediatric pharyngitis/tonsillitis
85. Lack of influence of beta-lactamase-producing flora on recovery of group A streptococci after treatment of acute pharyngitis
86. Eradication of group A streptococci from the upper respiratory tract by amoxicillin with clavulanate after oral penicillin V treatment failure
87. Treatment of patients with acute recurrent tonsillitis due to group A beta-hemolytic streptococci: A prospective randomized study comparing penicillin and amoxicillin/clavulanate potassium
88. Streptococcal pharyngitis: III. Streptococcal recurrence rates following therapy with penicillin or with clindamycin (7-chlorolincomycin)
89. The treatment of the carrier state of group A beta-hemolytic streptococci with clindamycin
90. Penicillin V and rifampin for the treatment of group A streptococcal pharyngitis: A randomized trial of 10 days penicillin vs 10 days penicillin with rifampin during the final 4 days of therapy
91. Penicillin plus rifampin eradicates pharyngeal carriage of group A streptococci
92. A comparison of the efficacy and safety of cefuroxime axetil and Augmentin in the treatment of upper respiratory tract infections
93. Les angines Enquête épidémiologique
94. Five day treatment of pharyngotonsillitis with cefpodoxime proxetil
95. Evaluation of cefadroxil penicillin and erythromycin in the treatment of streptococcal tonsillopharyngitis
96. Effective short-course treatment of acute group A beta hemolytic streptococcal tonsillopharyngitis: Ten days penicillin VK versus five days or ten days cefpodoxime proxetil in children
97. The effect of prescribed daily dose frequency on patient medication compliance
98. Strategies to improve compliance with therapy
99. Penicillin in streptococcal infections: Total dose and frequency of administration
100. Twice-daily penicillin in the treatment of streptococcal pharyngitis
101. Failure of once daily penicillin V therapy for streptococcal pharyngitis
102. A clinical experience with cefadroxil in upper respiratory tract infection
103. A multicenter, randomized, single-blind evaluation of cefuroxime axetil and phenoxymethyl penicillin in the treatment of streptococcal pharyngitis
104. Cefuroxime axetil and penicillin V compared in the treatment of group A beta-hemolytic streptococcal pharyngitis
105. Once daily therapy for streptococcal pharyngitis with cefadroxil
106. Randomized, single-blind evaluation of cefadroxil and phenoxymethyl penicillin in the treatment of streptococcal pharyngitis
107. Clinical comparison of once-daily cefadroxil and thrice-daily cefaclor in the treatment of streptococcal pharyngitis
108. Cefadroxil versus penicillin in the treatment of streptococcal tonsillopharyngitis
109. Therapy for pharyngitis and tonsillitis caused by group A beta-hemolytic streptococci: A meta-analysis comparing the efficacy and safety of cefadroxil monohydrate versus oral penicillin V
110. The effect of penicillin therapy on the symptoms and signs of streptococcal pharyngitis
111. Streptococcal pharyngitis: Placebo-controlled double-blind evaluation of clinical response to penicillin therapy
112. Effect of antibiotic therapy on the clinical course of streptococcal pharyngitis
113. Adverse and beneficial effects of immediate treatment of group A beta-hemolytic streptococcal pharyngitis with penicillin
114. Effect of types of treatment on development of antistreptolysin in patients with scarlet fever
115. The comparative effects of continuous and intermittent penicillin therapy on the formation of antistreptolysin in hemolytic streptococcal pharyngitis
116. Streptococcal bacteriostatic antibody in patients treated with penicillin
117. Studies on the prevention of rheumatic fever: The effect of time of initiation of treatment of streptococcal infections on the immune response of the host
118. Type-specific streptococcal antibody
119. Penicillin treatment and immunity to scarlatina
120. The prevention of type specific immunity to streptococcal infections due to the therapeutic use of penicillin
121. Penicillin in the prevention of scarlet fever
122. Immediate vs delayed treatment of group A beta-hemolytic streptococcal pharyngitis with penicillin V
123. Lack of impact of early antibiotic therapy for streptococcal pharyngitis on early recurrent rates
124. Association of penicillin tolerance with failure to eradicate group A streptococci from patients with pharyngitis
125. Penicillin tolerance in beta-streptococci isolated from patients with tonsillitis
126. An epidemic of penicillin-tolerant group A streptococcal pharyngitis in children living in closed community: Mass treatment with erythromycin
127. Evidence suggesting importance of role of interbacterial inhibition in maintaining balance of normal flora
128. Bacterial interference. I. Its occurrence among the respiratory tract flora and characterization of inhibition of group A streptococci by viridans streptococci
129. Bacterial interference: II. Role of the normal throat flora in prevention of colonization by group A Streptococcus
130. Bacterial interference: Effects of oral antibiotics on the normal throat flora and its ability to interfere with group A streptococci
131. Bacterial interference in the throat flora during streptococcal tonsillitis outbreak in an apartment house area
132. Bacterial interference: III. Effects of oral antibiotics on the normal throat flora and its ability to interfere with group A streptococci
133. Bacterial interference: IV. Epidemiological determinants of the antagonistic activity of the normal throat flora against group A streptococci
134. Interference of a-hemolytic streptococci isolated from tonsillar surface on ß-hemolytic streptococci (Streptococcus pyogenes)—A methodological study
135. Viridans, bacteriocins of alpha-hemolytic streptococci: Isolation, characterization, and partial purification
136. Distribution of bacteriocin production among group A hemolytic streptococci
137. Factors affecting production of the group A streptococcus bacteriocin SA-FF22
138. Evaluation of bacterial interference and ß-lactamase production in management of experimental infection with group A beta-hemolytic streptococci
139. Evaluation of beta-lactamase activity and microbial interference in treatment failures of acute streptococcal tonsillitis
140. Interfering a-streptococci as a protection against recurrent streptococcal tonsillitis in children
141. Alpha-streptococci as supplementary treatment of recurrent streptococcal tonsillitis: A randomized placebo-controlled study
142. Alpha-streptococci-inhibiting beta-streptococci group A in treatment of recurrent streptococcal tonsillitis
143. Diagnosis of streptococcal pharyngitis: Differentiation of active infection from the carrier state in the symptomatic child
144. Efficacy of benzathine penicillin G in group A streptococcal pharyngitis: Reevaluation
145. Failure of penicillin to eradicate group A streptococci during an outbreak of pharyngitis
146. Milder symptoms occur in recurrent episodes of streptococcal infection